| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3849963 | American Journal of Kidney Diseases | 2011 | 12 Pages |
Abstract
Our study supports a survival advantage of home HD without a difference between conventional and frequent/extended modalities. Suitably designed clinical trials of frequent/extended HD are needed to determine the presence and extent of mortality benefit with this modality.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Mark R. MBChB, MPH(Hons), FRACP, Carmel M. MB,BS(Hons), MMedSci, FRACP, Peter G. MB,BS, PhD, FRACP, Kevan R. BHB, MBChB, MClinEpi, PhD, FRACP, Roger J. PhD, John W.M. MB,BS, FRCP(Lond), FRACP, Stephen P. MB,BS(Hons), PhD, FRACP,